Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Researchers have observed that BPC-157 interacts with the nitric oxide (NO) system, the dopamine system, and the prostaglandin pathway, suggesting a multi-targeted mechanism of action that goes beyond simple wound closure
On concentrations, published research clusters around 1% for finished products
Takeaway: If insomnia is entrenched, CBT-I is foundational
PT-141 Synonyms / Designations: PT-141, Bremelanotide, Melanotan II analogue CAS Number: 189691-06-3 Molecular Formula: C50H68N14O10 Molecular Weight: ~1025.18 g/mol Peptide Length: 7 amino acids (cyclic peptide) Peptide Type: Synthetic melanocortin receptor agonist Purity: 99 % (HPLC, typical) Appearance: White to off-white lyophilised powder Pack Size: 10 mg (typical) Storage : Desiccated, protected from light, stored at 20 C or below Solubility: Soluble in water and buffered aqueous solutions Description & Mechanism PT-141 is a synthetic cyclic heptapeptide derived from melanocortin peptides and developed for experimental investigation of melanocortin receptormediated signalling pathways
